Evaluating palliative care case conferences in primary care for patients with advanced non-malignant chronic conditions: a cluster-randomised controlled trial (KOPAL)

医学 生活质量(医疗保健) 慢性阻塞性肺病 缓和医疗 入射(几何) 随机对照试验 物理疗法 急诊医学 内科学 护理部 物理 光学
作者
Tina Mallon,Josefine Schulze,Judith Dams,Jan Weber,Thomas Asendorf,Silke Böttcher,Uta Sekanina,Franziska Schade,Nils Schneider,M. Freitag,Christiane Müller,Hans‐Helmut König,Friedemann Nauck,Tim Friede,Martin Scherer,Gabriella Marx
出处
期刊:Age and Ageing [Oxford University Press]
卷期号:53 (5) 被引量:2
标识
DOI:10.1093/ageing/afae100
摘要

Abstract Background Patients with congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD) and dementia are underrepresented in specialist palliative home care (SPHC). However, the complexity of their conditions requires collaboration between general practitioners (GPs) and SPHC teams and timely integration into SPHC to effectively meet their needs. Objective To facilitate joint palliative care planning and the timely transfer of patients with advanced chronic non-malignant conditions to SPHC. Methods A two-arm, unblinded, cluster-randomised controlled trial. 49 GP practices in northern Germany were randomised using web-based block randomisation. We included patients with advanced CHF, COPD and/or dementia. The KOPAL intervention consisted of a SPHC nurse–patient consultation followed by an interprofessional telephone case conference between SPHC team and GP. The primary outcome was the number of hospital admissions 48 weeks after baseline. Secondary analyses examined the effects on health-related quality of life and self-rated health status, as measured by the EuroQol 5D scale. Results A total of 172 patients were included in the analyses. 80.4% of GP practices had worked with SHPC before, most of them exclusively for cancer patients. At baseline, patients reported a mean EQ-VAS of 48.4, a mean quality of life index (EQ-5D-5L) of 0.63 and an average of 0.80 hospital admissions in the previous year. The intervention did not significantly reduce hospital admissions (incidence rate ratio = 0.79, 95%CI: [0.49, 1.26], P = 0.31) or the number of days spent in hospital (incidence rate ratio = 0.65, 95%CI: [0.28, 1.49], P = 0.29). There was also no significant effect on quality of life (∆ = −0.02, 95%CI: [−0.09, 0.05], P = 0.53) or self-rated health (∆ = −2.48, 95%CI: [−9.95, 4.99], P = 0.51). Conclusions The study did not show the hypothesised effect on hospitalisations and health-related quality of life. Future research should focus on refining this approach, with particular emphasis on optimising the timing of case conferences and implementing discussed changes to treatment plans, to improve collaboration between GPs and SPHC teams.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hyeah应助简单采纳,获得10
刚刚
QinQin发布了新的文献求助10
2秒前
zl1733关注了科研通微信公众号
2秒前
正直的笑蓝完成签到,获得积分10
4秒前
NexusExplorer应助帅玉玉采纳,获得10
4秒前
4秒前
qq发布了新的文献求助10
5秒前
6秒前
荆玉豪发布了新的文献求助20
6秒前
zz完成签到 ,获得积分10
6秒前
7秒前
董董完成签到,获得积分20
7秒前
7秒前
不想学习发布了新的文献求助10
7秒前
liuxia完成签到,获得积分10
8秒前
8秒前
婷婷发布了新的文献求助10
9秒前
Winnie发布了新的文献求助10
9秒前
张靖雯发布了新的文献求助10
10秒前
心灵美鑫完成签到 ,获得积分10
11秒前
辛勤芷容完成签到,获得积分10
11秒前
乐乐应助QinQin采纳,获得10
11秒前
silence发布了新的文献求助10
12秒前
量子星尘发布了新的文献求助10
13秒前
13秒前
14秒前
难过的班完成签到,获得积分10
14秒前
别说话发布了新的文献求助10
15秒前
Azyyyy完成签到,获得积分10
15秒前
15秒前
16秒前
大可奇完成签到,获得积分10
17秒前
魔猿发布了新的文献求助10
17秒前
英俊的铭应助念念采纳,获得10
17秒前
yh发布了新的文献求助50
17秒前
量子星尘发布了新的文献求助10
18秒前
19秒前
19秒前
今后应助www采纳,获得10
19秒前
大可奇发布了新的文献求助10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
从k到英国情人 1500
Ägyptische Geschichte der 21.–30. Dynastie 1100
„Semitische Wissenschaften“? 1100
Russian Foreign Policy: Change and Continuity 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5730272
求助须知:如何正确求助?哪些是违规求助? 5322398
关于积分的说明 15318370
捐赠科研通 4876855
什么是DOI,文献DOI怎么找? 2619709
邀请新用户注册赠送积分活动 1569121
关于科研通互助平台的介绍 1525755